AN2 Therapeutics (ANTX) vs Whitehawk Therapeutics (WHWK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
AN2 Therapeutics (ANTX) has outperformed Whitehawk Therapeutics (WHWK) over the past year, gaining 262.8% versus a gain of 62.9%. Whitehawk Therapeutics is the larger company by market cap ($200.7 million vs $166.0 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANTX | WHWK |
|---|---|---|
| Share price | $4.40 | $3.52 |
| Market cap | $166.04M | $200.67M |
| 1-day change | -5.98% | +1.44% |
| YTD return | +310.53% | +43.39% |
| 1-year return | +262.79% | +62.91% |
| 5-year return | — | -87.25% |
| EPS (TTM) | $-1.05 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.19 | $5.50 |
| 52-week low | $1.00 | $1.87 |
| Distance from 52-week high | -38.80% | -35.94% |
| Analyst consensus | none | buy |
| Avg. price target upside | +104.55% | +119.03% |
| Average volume | 240.21K | 367.72K |
| Shares outstanding | 37.74M | 57.01M |
| Employees | 21 | 32 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANTX has outperformed WHWK by 199.9 percentage points over the past year.
About AN2 Therapeutics
ANTX stock →AN2 Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics. The company's initial candidate includes epetraborole, which is phase 3 clinical trial as a once-daily oral treatment for patients with non-tuberculous mycobacterial lung disease, as well as studying for the treatment of acute melioidosis.
Health Care · Biotechnology: Pharmaceutical Preparations · 21 employees
About Whitehawk Therapeutics
WHWK stock →Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 32 employees
ANTX vs WHWK FAQ
Which is bigger, AN2 Therapeutics or Whitehawk Therapeutics?
Whitehawk Therapeutics (WHWK) is larger, with a market capitalization of $200.67M compared with $166.04M for AN2 Therapeutics (ANTX).
Which stock has performed better over the past year, ANTX or WHWK?
ANTX returned +262.79% over the past 12 months, compared with +62.91% for WHWK (price return, excluding dividends). Past performance does not predict future results.
Are AN2 Therapeutics and Whitehawk Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.